Return to homepagePandemic Pact

Liberate: Imprecence biomarkers to remodeling (FAPI PET/CT)- On the way to personalized diagnosis

  • Funded by Netherlands Organisation for Health Research and Development (ZonMW)
  • Total publications:0 publications

Grant number: 1.04302E+13

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2024.0
    2025.0

  • Known Financial Commitments (USD)

    $0

  • Funder

    Netherlands Organisation for Health Research and Development (ZonMW)

  • Principal Investigator

    prof dr AH (Anke-Hilse) Maitland-van der Zee

  • Research Location

    Netherlands

  • Lead Research Institution

    Amsterdam UMC Locatie AMC

  • Research Priority Alignment

    N/A

  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Prognostic factors for disease severity

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

Even a year after a SARS-COV-2 infection, 10% of patients still have serious complaints. Biomarkers to identify phenotypes of severe and long-term lung-covid are not yet available. There is a need to find these biomarkers, because knowing the phenotype can help to choose the best therapy for an individual patient. This project is a follow-up to the P4O2 Long-Covid project (financed by Health-Holland), which started in 2020.